Verrica Pharmaceuticals Inc. (VRCA) Tops Q1 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- L3Harris CEO steps down amid conduct review, shares drop
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Verrica Pharmaceuticals (VRCA) PT Raised to $12 at Jefferies
May 14, 2024 9:35 AM EDTJefferies analyst Glen Santangelo raised the price target on Verrica Pharmaceuticals (NASDAQ: VRCA) to $12.00 (from $10.00) while maintaining a Buy rating.
The analyst comments "Updating model to reflect 1Q results. Overall, we remain encouraged with the launch and continue to see opportunity for... More
